Bill
Bill > A3487
NJ A3487
NJ A3487Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.
summary
Introduced
03/08/2022
03/08/2022
In Committee
03/08/2022
03/08/2022
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.
AI Summary
This bill, the "New Jersey Right to Try-Plus Act," permits terminally ill patients to access certain investigational and off-label treatments. It allows manufacturers to provide investigational drugs, biological products, or devices to eligible patients, and requires hospitals to provide and administer FDA-approved drugs, biological products, or devices for off-label use to eligible patients. The bill aims to give terminally ill patients access to a broader range of treatment options, including those that are still under investigation or approved for other purposes, in consultation with their healthcare providers and with informed consent.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 03/08/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/A3487 |
| BillText | https://pub.njleg.gov/Bills/2022/A3500/3487_I1.HTM |
| Bill | https://pub.njleg.gov/Bills/2022/A3500/3487_I1.PDF |
| BillText | https://www.njleg.state.nj.us/Bills/2022/A3500/3487_I1.HTM |
| Bill | https://www.njleg.state.nj.us/Bills/2022/A3500/3487_I1.PDF |
Loading...